Search

Author/Creator Yu, Alice L

1. Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study. Issue 2 (22nd July 2020)

Authors:
Huang, Chiun-Sheng; Yu, Alice L; Tseng, Ling-Ming; Chow, Louis W C; Hou, Ming-Feng; Hurvitz, Sara A; Schwab, Richard B; L Murray, James; Chang, Hsien-Kun; Chang, Hong-Tai; Chen, Shin-Cheh; Kim, Sung-Bae; Hung, Jung-Tung; Ueng, Shir-Hwa; Lee, Su-Hua; Chen, Chwen-Cheng; Rugo, Hope S
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial. Issue 7 (July 2017)

Authors:
Mody, Rajen; Naranjo, Arlene; Van Ryn, Collin; Yu, Alice L; London, Wendy B; Shulkin, Barry L; Parisi, Marguerite T; Servaes, Sabah-E-Noor; Diccianni, Mitchell B; Sondel, Paul M; Bender, Julia G; Maris, John M; Park, Julie R; Bagatell, Rochelle
Journal:
Lancet oncology
Issue:
Volume 18:Issue 7(2017:Jul.)
Page Start:
946
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group. Issue 2 (23rd February 2023)

Authors:
Erbe, Amy K; Diccianni, Mitch B; Mody, Rajen; Naranjo, Arlene; Zhang, Fan F; Birstler, Jen; Kim, KyungMann; Feils, Arika S; Hung, Jung-Tung; London, Wendy B; Shulkin, Barry L; Mathew, Varsha; Parisi, Marguerite T; Servaes, Sabah; Asgharzadeh, Shahab; Maris, John M; Park, Julie; Yu, Alice L; Sonde...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 2(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Metabolic characteristics of 13‐cis‐retinoic acid (isotretinoin) and anti‐tumour activity of the 13‐cis‐retinoic acid metabolite 4‐oxo‐13‐cis‐retinoic acid in neuroblastoma. (December 2014)

Authors:
Sonawane, Poonam; Cho, Hwang Eui; Tagde, Ashujit; Verlekar, Dattesh; Yu, Alice L; Reynolds, C Patrick; Kang, Min H
Journal:
British journal of pharmacology
Issue:
Volume 171:Number 23(2014:Dec.)
Page Start:
5330
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancer. Issue 6 (22nd June 2022)

Authors:
Hung, Jung-Tung; Chen, I-Ju; Ueng, Shir-Hwa; Huang, Chiun-Sheng; Chen, Shin-Cheh; Chen, Mu-Yi; Lin, Yung-Chang; Lin, Chun-Yen; Campbell, Michael J; Rugo, Hope S; Yu, Alice L
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗